Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 130
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 105(16): 6051-6, 2008 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-18417454

RESUMEN

Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) are essential for responses to interferons (IFNs), most cytokines, and some growth factors. JAK/STAT signaling is not, however, sufficient for a full IFN-gamma response. Here, a convenient, robust, and quantitative flow cytometry-based kinome-wide siRNA screen has identified nine additional kinases as required for the IFN-gamma class II HLA response, seven for an antiviral response, and two for the cytopathic response to encephalomyocarditis virus (EMCV). As one example, inhibition of the IFN-gamma response by siRNA to ataxia telangiectasia-mutated (ATM) differentially affects a spectrum of IFN-gamma-stimulated mRNAs, with inhibitions being seen as early as 1 h after IFN-gamma stimulation. The implication of ATM, with its previously recognized function in chromatin decondensation, in the control of transcription early in the IFN-gamma response highlights both a role for ATM in cytokine responses and a possible correlation with the chromatin decondensation recently observed in response to IFN-gamma in mammalian cells. This work has, therefore, revealed the simplicity, power, and convenience of quantitative flow cytometry-based siRNA screens, a requirement for ATM and multiple additional kinases in the IFN-gamma response and a possible requirement for two of these kinases in the cytopathic response to EMCV.


Asunto(s)
Citometría de Flujo/métodos , Interferón gamma/inmunología , Fosfotransferasas/análisis , ARN Interferente Pequeño/farmacología , Animales , Proteínas de la Ataxia Telangiectasia Mutada , Proteínas de Ciclo Celular/análisis , Proteínas de Ciclo Celular/antagonistas & inhibidores , Proteínas de Ciclo Celular/genética , Línea Celular Tumoral , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/antagonistas & inhibidores , Proteínas de Unión al ADN/genética , Antígenos de Histocompatibilidad Clase II/inmunología , Humanos , Ratones , Neoplasias/enzimología , Neoplasias/inmunología , Fosfotransferasas/antagonistas & inhibidores , Fosfotransferasas/genética , Proteínas Serina-Treonina Quinasas/análisis , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/genética , ARN Interferente Pequeño/genética , Factor de Transcripción STAT1/análisis , Factor de Transcripción STAT1/antagonistas & inhibidores , Factor de Transcripción STAT1/genética , Proteínas Supresoras de Tumor/análisis , Proteínas Supresoras de Tumor/antagonistas & inhibidores , Proteínas Supresoras de Tumor/genética , Virus/inmunología
2.
Proteomics ; 1(6): 767-72, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11677783

RESUMEN

The interferons and interleukin-6 (IL-6) family cytokines exert their biological effects via Janus kinase and signal transducer and activator of transcription (JAK-STAT) signalling pathways. Our aim is to identify "novel" signalling molecules not previously implicated in JAK-mediated signalling. Phosphotyrosine profiles of either whole cell lysates, or subcellular fractions, of unstimulated and cytokine-treated cell lines have been analysed and ligand-inducible differences observed. Recombinant src homology 2 domains, biotinylated peptides corresponding to cytokine receptor intracellular domains, antiphosphotyrosine antibodies, anion exchange columns and 2-D phosphotyrosine profiling have been used to select cohorts of molecules that are tyrosine phosphorylated in response to cytokine treatment. Tyrosine phosphorylated proteins showing cytokine specificity or differential profiles in cell lines mutated in specific JAKs are being purified and identified by mass spectrometry.


Asunto(s)
Interferones/metabolismo , Interleucina-6/metabolismo , Fosfotirosina/metabolismo , Transducción de Señal , Western Blotting , Línea Celular , Cromatografía de Afinidad , Cromatografía por Intercambio Iónico , Electroforesis en Gel Bidimensional , Humanos , Pruebas de Precipitina , Proteínas Recombinantes de Fusión/metabolismo
3.
EMBO J ; 20(19): 5431-42, 2001 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-11574475

RESUMEN

A tripartite receptor comprising the external region of the erythropoietin (Epo) receptor, the transmembrane and JAK-binding domains of the gp130 subunit of the interleukin-6 (IL-6) receptor, and a seven amino acid STAT1 recruitment motif (Y440) from the interferon (IFN)-gamma receptor, efficiently mediates an IFN-gamma-like response. An analogous completely foreign chimeric receptor in which the Y440 motif is replaced with the Y905 motif from gp130 also mediates an IFN-gamma-like response, but less efficiently. The IFNGR1 signal-transducing subunit of the IFN-gamma receptor is tyrosine phosphorylated through the chimeric receptors and the endogenous IL-6 and OSM receptors. Cross phosphorylation of IFNGR1 is not, however, required for the IFN-gamma-like response through the chimeric receptors, nor does it mediate an IFN-gamma-like response to IL-6 or OSM. The data argue strongly for modular JAK/STAT signalling and against any rigid structural organization for the "pathways" involved. They emphasize the likely high degree of overlap between the signals generated from disparate JAK-receptor complexes and show that relatively minor changes in such complexes can profoundly affect the response.


Asunto(s)
Interferón gamma/metabolismo , Proteínas Nucleares , Receptores Inmunológicos/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Antígenos de Histocompatibilidad Clase II/biosíntesis , Humanos , Receptor de Interferón alfa y beta , Receptores de Eritropoyetina/genética , Receptores de Eritropoyetina/metabolismo , Receptores Inmunológicos/genética , Receptores de Interferón/genética , Receptores de Interferón/metabolismo , Receptores de Interleucina-6/genética , Receptores de Interleucina-6/metabolismo , Factor de Transcripción STAT1 , Transducción de Señal , Transactivadores/biosíntesis , Transactivadores/metabolismo , Receptor de Interferón gamma
4.
FEBS Lett ; 505(1): 87-91, 2001 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-11557047

RESUMEN

The terminal portion of the Janus kinases (Jaks) contains a divergent FERM (Four-point-one, Ezrin, Radixin, Moesin) homology domain comprising 19 conserved hydrophobic regions. To determine the role of this domain in governing recruitment of Jak1, but not Jak3, to the gp130 subunit of the interleukin-6 family of cytokine receptors, the interaction of three Jak1/Jak3 chimeras with gp130 was investigated. Chimeras 1, 2 and 3 (Jak1 FERM regions 1-19, 1-18 and 1-8/Jak3, respectively) were all enzymically active. Chimeras 1 and 2 interacted with the cytoplasmic domain of gp130, although less efficiently than Jak1. Only chimera 2, however, restored gp130 signalling in Jak1-negative cells. The data are consistent with recruitment of Jak1 to gp130 through the Jak1 FERM domain, but also emphasise the likely requirement for precise Jak/receptor orientation to sustain function.


Asunto(s)
Antígenos CD/metabolismo , Glicoproteínas de Membrana/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Receptor gp130 de Citocinas , Citoplasma/metabolismo , Proteínas de Unión al ADN/metabolismo , Fibrosarcoma , Humanos , Janus Quinasa 1 , Janus Quinasa 3 , Datos de Secuencia Molecular , Estructura Terciaria de Proteína , Proteínas Tirosina Quinasas/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Factor de Transcripción STAT1 , Transducción de Señal , Transactivadores/metabolismo , Células Tumorales Cultivadas
5.
Genomics ; 77(1-2): 50-7, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11543632

RESUMEN

The combination of high and low density cDNA filter array technology potentially permits both the identification of subsets of induced genes and convenient and rapid multisample expression profiling of such subsets under a variety of conditions. The JAK/STAT1 pathway for IFN-gamma signaling in human cells has been well characterized, but the extent and importance of additional pathways remain to be established. Here, using high-density filter arrays of the RZPD UniGene set, we identified 18 novel IFN-gamma-inducible genes. Expression profiling was carried out using low-density arrays representing both novel and known IFN-gamma-inducible genes. Initial experiments failed to detect evidence for any novel non-JAK-dependent pathways in cells expressing a kinase-dead JAK2. The data, however, validated the potential of the combined methods in establishing rapid and convenient expression profiling of several hundred genes in response to any ligand of choice.


Asunto(s)
Perfilación de la Expresión Génica , Interferón gamma/farmacología , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Proteínas Proto-Oncogénicas , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Janus Quinasa 2 , Proteínas Tirosina Quinasas/genética , Proteínas Tirosina Quinasas/fisiología , Transducción de Señal , Células Tumorales Cultivadas
6.
J Biol Chem ; 276(40): 37451-8, 2001 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-11468294

RESUMEN

Janus kinase 1 (Jak1) is a cytoplasmic tyrosine kinase that noncovalently associates with a variety of cytokine receptors. Here we show that the in vitro translated N-terminal domains of Jak1 are sufficient for binding to a biotinylated peptide comprising the membrane-proximal 73 amino acids of gp130, the signal-transducing receptor chain of interleukin-6-type cytokines. By the fold recognition approach amino acid residues 36-112 of Jak1 were predicted to adopt a beta-grasp fold, and a structural model was built using ubiquitin as a template. Substitution of Tyr(107) to alanine, a residue conserved among Jaks and involved in hydrophobic core interactions of the proposed beta-grasp domain, abrogated binding of full-length Jak1 to gp130 in COS-7 transfectants. By further mutagenesis we identified the loop 4 region of the Jak1 beta-grasp domain as essential for gp130 association and gp130-mediated signal transduction. In Jak1-deficient U4C cells reconstituted with the loop 4 Jak1 mutants L80A/Y81A and Delta(Tyr(81)-Ser(84)), the interferon-gamma, interferon-alpha, and interleukin-6 responses were similarly impaired. Thus, loop 4 of the beta-grasp domain plays a role in the association of Jak1 with both class I and II cytokine receptors. Taken together the structural model and the mutagenesis data provide further insight into the interaction of Janus kinases with cytokine receptors.


Asunto(s)
Proteínas Tirosina Quinasas/metabolismo , Receptores de Citocinas/metabolismo , Alanina/genética , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Animales , Antígenos CD/metabolismo , Sitios de Unión , Células COS , Receptor gp130 de Citocinas , Interferones/farmacología , Janus Quinasa 1 , Glicoproteínas de Membrana/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Estructura Terciaria de Proteína , Proteínas Tirosina Quinasas/química , Proteínas Tirosina Quinasas/genética , Homología de Secuencia de Aminoácido , Transducción de Señal , Tirosina/genética , Tirosina/metabolismo
7.
EMBO J ; 20(10): 2508-17, 2001 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-11350940

RESUMEN

The binding of interferons (IFNs) to their receptors leads to the phosphorylation and activation of signal transducers and activators of transcription (STATs), and their translocation from the cytoplasm to the nucleus. The mechanisms by which the STATs move to the nuclear pore are not, however, known. Here it is shown that IFN-alpha and -gamma signalling and STAT1 translocation are independent of the actin cytoskeleton or microtubules. Using fluorescence loss in photobleaching (FLIP) and fluorescence recovery after photobleaching (FRAP) experiments, the mobility of a fusion protein of STAT1 with green fluorescent protein (STAT1-GFP) was compared with that of GFP and protein kinase C-GFP. In IFN-gamma-treated and control cells, cytoplasmic STAT1-GFP shows high, energy-independent, mobility comparable to that of freely diffusible GFP. A random walk model for movement of STAT1 from the plasma membrane to the nuclear pore is, therefore, indicated. Nuclear STAT1-GFP showed similar high mobility, with exclusion from nucleoli, consistent with high rates of association and dissociation of STAT1-DNA and/or STAT1-protein complexes in the nucleoplasm of the cell.


Asunto(s)
Membrana Celular/metabolismo , Proteínas de Unión al ADN/metabolismo , ADN/metabolismo , Transactivadores/metabolismo , Transporte Biológico , Nucléolo Celular/metabolismo , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Citoesqueleto , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/fisiología , Fluorescencia , Humanos , Interferón-alfa/metabolismo , Interferón-alfa/farmacología , Interferón gamma/metabolismo , Interferón gamma/farmacología , Proteínas de la Membrana , Proteína Quinasa 8 Activada por Mitógenos , Proteína Quinasa 9 Activada por Mitógenos , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Receptor de Interferón alfa y beta , Receptores de Interferón/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Recombinantes de Fusión/fisiología , Factor de Transcripción STAT1 , Transducción de Señal/fisiología , Transactivadores/genética , Transactivadores/fisiología , Células Tumorales Cultivadas , Receptor de Interferón gamma
8.
Annu Rev Biochem ; 67: 227-64, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9759489

RESUMEN

Interferons play key roles in mediating antiviral and antigrowth responses and in modulating immune response. The main signaling pathways are rapid and direct. They involve tyrosine phosphorylation and activation of signal transducers and activators of transcription factors by Janus tyrosine kinases at the cell membrane, followed by release of signal transducers and activators of transcription and their migration to the nucleus, where they induce the expression of the many gene products that determine the responses. Ancillary pathways are also activated by the interferons, but their effects on cell physiology are less clear. The Janus kinases and signal transducers and activators of transcription, and many of the interferon-induced proteins, play important alternative roles in cells, raising interesting questions as to how the responses to the interferons intersect with more general aspects of cellular physiology and how the specificity of cytokine responses is maintained.


Asunto(s)
Antivirales/metabolismo , Interferones/metabolismo , Transducción de Señal , Antivirales/inmunología , Interferones/inmunología
9.
Growth Factors ; 16(1): 39-51, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9777369

RESUMEN

The basic framework for the JAK/STAT pathway is well documented. Recruitment of latent cytoplasmic STAT transcription factors to tyrosine phosphorylated docking sites on cytokine receptors and their JAK-mediated phosphorylation instigates their translocation to the nucleus and their ability to bind DNA. The biochemical processes underlying recruitment and activation of this pathway have commonly been studied in reconstituted in vitro systems using previously defined recombinant signaling components. We have dissected the Interferon gamma (IFN gamma) signal transduction pathway in crude extracts from wild-type and STAT1-negative mutant cell lines by real-time BIAcore analysis, size-exclusion (SE) chromatography and immuno-detection. The data indicate that in detergent-free cell extracts: (1) the phospho-tyrosine (Y440P)-containing peptide motif of the IFN gamma-receptor alpha-chain interacts directly with STAT1, or STAT1 complexes, and no other protein; (2) non-activated STAT1 is present in a higher molecular weight complex(es) and, at least for IFN gamma-primed cells, is available for recruitment to the activated IFN gamma-receptor from only a subset of such complexes; (3) activated STAT1 is released from the receptor as a monomer.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Interferón gamma/metabolismo , Receptores de Interferón/metabolismo , Transducción de Señal , Transactivadores/metabolismo , Secuencia de Aminoácidos , Línea Celular , Núcleo Celular/metabolismo , Cromatografía Líquida de Alta Presión , Citoplasma/metabolismo , Proteínas de Unión al ADN/genética , Células HeLa , Humanos , Immunoblotting , Interferón gamma/genética , Interferón gamma/farmacología , Janus Quinasa 3 , Datos de Secuencia Molecular , Peso Molecular , Fragmentos de Péptidos/metabolismo , Fosforilación , Proteínas Tirosina Quinasas/metabolismo , Factor de Transcripción STAT1 , Transactivadores/genética , Transcripción Genética , Tirosina/metabolismo , Dominios Homologos src , Receptor de Interferón gamma
10.
Biochem J ; 335 ( Pt 3): 557-65, 1998 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-9794795

RESUMEN

Stimulation of the interleukin-6 (IL-6) signalling pathway occurs via the IL-6 receptor-glycoprotein 130 (IL-6R-gp130) receptor complex and results in the regulation of acute-phase protein genes in liver cells. Ligand binding to the receptor complex leads to tyrosine phosphorylation and activation of Janus kinases (Jak), phosphorylation of the signal transducing subunit gp130, followed by recruitment and phosphorylation of the signal transducer and activator of transcription factors STAT3 and STAT1 and the src homology domain (SH2)-containing protein tyrosine phosphatase (SHP2). The tyrosine phosphorylated STAT factors dissociate from the receptor, dimerize and translocate to the nucleus where they bind to enhancer sequences of IL-6 target genes. Phosphorylated SHP2 is able to bind growth factor receptor bound protein (grb2) and thus might link the Jak/STAT pathway to the ras/raf/mitogen-activated protein kinase pathway. Here we present data on the dose-dependence, kinetics and kinase requirements for SHP2 phosphorylation after the activation of the signal transducer, gp130, of the IL-6-type family receptor complex. When human fibrosarcoma cell lines deficient in Jak1, Jak2 or tyrosine kinase 2 (Tyk2) were stimulated with IL-6-soluble IL-6R complexes it was found that only in Jak1-, but not in Jak 2- or Tyk2-deficient cells, SHP2 activation was greatly impaired. It is concluded that Jak1 is required for the tyrosine phosphorylation of SHP2. This phosphorylation depends on Tyr-759 in the cytoplasmatic domain of gp130, since a Tyr-759-->Phe exchange abrogates SHP2 activation and in turn leads to elevated and prolonged STAT3 and STAT1 activation as well as enhanced acute-phase protein gene induction. Therefore, SHP2 plays an important role in acute-phase gene regulation.


Asunto(s)
Antígenos CD/fisiología , Interleucina-6/fisiología , Glicoproteínas de Membrana/fisiología , Proteínas Tirosina Fosfatasas/metabolismo , Proteínas Proto-Oncogénicas , Transducción de Señal , Antígenos CD/química , Carcinoma Hepatocelular , Receptor gp130 de Citocinas , Proteínas de Unión al ADN/metabolismo , Activación Enzimática , Humanos , Interleucina-6/farmacología , Péptidos y Proteínas de Señalización Intracelular , Janus Quinasa 1 , Janus Quinasa 2 , Neoplasias Hepáticas , Glicoproteínas de Membrana/química , Mutagénesis Sitio-Dirigida , Proteína Tirosina Fosfatasa no Receptora Tipo 11 , Proteína Tirosina Fosfatasa no Receptora Tipo 6 , Proteínas Tirosina Quinasas/metabolismo , Proteínas/metabolismo , Receptores de Interleucina-6/fisiología , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Tirosina Fosfatasas con Dominio SH2 , Factor de Transcripción STAT3 , TYK2 Quinasa , Transactivadores/metabolismo , Células Tumorales Cultivadas , Dominios Homologos src
11.
J Biol Chem ; 273(36): 22962-8, 1998 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-9722518

RESUMEN

Numerous cytokines, growth, and differentiation factors elicit their intracellular responses via Janus tyrosine kinases (Jaks) and transcription factors of the STAT (signal transducer and activator of transcription) family. Additionally, environmental stress (UV light, heat, aniso-osmolarity, and radicals) has recently been shown to activate intracellular signaling cascades such as the stress-activated protein kinases and nuclear factor-kappaB. In this study, we demonstrate that in different cell lines a particular stress, namely hyperosmolarity, results in tyrosine phosphorylation of the Janus kinases Jak1, Jak2, and Tyk2 and in the activation of STAT1 and/or STAT3. Both transcription factors are phosphorylated at a specific tyrosine residue and translocation to the nucleus was demonstrated by the use of a STAT3/green fluorescent protein fusion protein. A prominent role for Jak1 in the activation of STATs by hypertonicity was demonstrated by the use of Jak-deficient cell lines. Stress-activated STAT1 and STAT3 transactivate a reporter gene containing the acute-phase response element of the rat alpha2-macroglobulin promoter. Experiments using a diffusible solute suggest that not the increase in intracellular osmolarity but the resultant cell shrinkage is the trigger for Jak/STAT activation.


Asunto(s)
Presión Osmótica , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas , Activación Transcripcional , Animales , Células COS , Tamaño de la Célula , Proteínas de Unión al ADN/metabolismo , Células HeLa , Humanos , Janus Quinasa 1 , Janus Quinasa 2 , Fosforilación , Proteínas/metabolismo , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Transducción de Señal , TYK2 Quinasa , Transactivadores/metabolismo
12.
J Biol Chem ; 273(25): 15719-26, 1998 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-9624169

RESUMEN

Growth hormone (GH) and prolactin (PRL) binding to their receptors, which belong to the cytokine receptor superfamily, activate Janus kinase (JAK) 2 tyrosine kinase, thereby leading to their biological actions. We recently showed that GH mainly stimulated tyrosine phosphorylation of epidermal growth factor receptor and its association with Grb2, and concomitantly stimulated mitogen-activated protein kinase activity in liver, a major target tissue. Using specific antibodies, we now show that GH was also able to induce tyrosine phosphorylation of insulin receptor substrate (IRS)-1/IRS-2 in liver. In addition, the major tyrosine-phosphorylated protein in anti-p85 phosphatidylinositol 3-kinase (PI3-kinase) immunoprecipitate from liver of wild-type mice was IRS-1, and IRS-2 in IRS-1 deficient mice, but not epidermal growth factor receptor. These data suggest that tyrosine phosphorylation of IRS-1 may be a major mechanism for GH-induced PI3-kinase activation in physiological target organ of GH, liver. We also show that PRL was able to induce tyrosine phosphorylation of both IRS-1 and IRS-2 in COS cells transiently transfected with PRLR and in CHO-PRLR cells. Moreover, we show that tyrosine phosphorylation of IRS-3 was induced by both GH and PRL in COS cells transiently transfected with IRS-3 and their cognate receptors. By using the JAK2-deficient cell lines or by expressing a dominant negative JAK2 mutant, we show that JAK2 is required for the GH- and PRL-dependent tyrosine phosphorylation of IRS-1, -2, and -3. Finally, a specific PI3-kinase inhibitor, wortmannin, completely blocked the anti-lipolytic effect of GH in 3T3 L1 adipocytes. Taken together, the role of IRS-1, -2, and -3 in GH and PRL signalings appears to be phosphorylated by JAK2, thereby providing docking sites for p85 PI3-kinase and activating PI3-kinase and its downstream biological effects.


Asunto(s)
Hormona del Crecimiento/farmacología , Fosfatidilinositol 3-Quinasas/metabolismo , Fosfoproteínas/metabolismo , Prolactina/farmacología , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas , Receptor de Insulina/metabolismo , Tirosina/metabolismo , Androstadienos/farmacología , Animales , Activación Enzimática , Antagonistas de Insulina/farmacología , Proteínas Sustrato del Receptor de Insulina , Péptidos y Proteínas de Señalización Intracelular , Janus Quinasa 2 , Hígado/efectos de los fármacos , Hígado/enzimología , Ratones , Wortmanina
13.
Biochem J ; 331 ( Pt 3): 695-702, 1998 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-9560294

RESUMEN

The transmembrane glycoprotein gp130 is involved in many cytokine-mediated cellular responses and acts therein as the signal transducing receptor subunit. Interleukin-6 (IL-6) and interleukin-11 (IL-11), in complex with their specific alpha-receptors, homodimerize gp130 and, as a consequence, activate the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) signalling pathway in their target cells. So far, it is not clear whether gp130 is bound to these cytokines and their specific alpha-receptor subunits through identical or different epitopes. In order to study the interaction of IL-11 and IL-11R with human gp130 the soluble form of the recently cloned human IL-11R was expressed in baculovirus-infected insect cells. By a coprecipitation binding-assay it is demonstrated that IL-11 and IL-6 compete for binding to gp130. Using deletion and point mutants of gp130 it is shown that IL-11-IL-11R and IL-6-IL-6R recognize overlapping binding motifs on gp130. Moreover, using well-established Jak-deficient cell lines we demonstrate that STAT activation by IL-11 requires Jak1. Taken together, our data support the concept that IL-6 and IL-11 activate gp130 by very similar molecular mechanisms.


Asunto(s)
Antígenos CD/metabolismo , Interleucina-11/farmacología , Interleucina-6/farmacología , Glicoproteínas de Membrana/metabolismo , Transducción de Señal/fisiología , Animales , Antígenos CD/genética , Unión Competitiva/fisiología , División Celular/efectos de los fármacos , Línea Celular , Receptor gp130 de Citocinas , Proteínas de Unión al ADN/metabolismo , Dimerización , Epítopos/inmunología , Humanos , Subunidad alfa del Receptor de Interleucina-11 , Glicoproteínas de Membrana/genética , Mutación/genética , Proteínas Tirosina Quinasas/metabolismo , Receptores de Interleucina/metabolismo , Receptores de Interleucina-11 , Receptores de Interleucina-6/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Recombinantes/metabolismo , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Transactivadores/metabolismo
14.
J Biol Chem ; 272(39): 24183-90, 1997 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-9305869

RESUMEN

In addition to a role in response to insulin and insulin-like growth factors, insulin receptor substrate 1 (IRS-1) is phosphorylated in response to IL-4, the interferons (IFNs) and oncostatin M (OSM). Here mutant cell lines lacking JAK1, JAK2, or Tyk2 were used to determine the role(s) of the Janus kinase (JAK) family of protein-tyrosine kinases in IRS-1 phophorylation. 32D cells, which do not express IRS proteins, were analyzed for any requirement for these proteins in response to the IFNs. For the mutant human fibrosarcoma cell lines, phosphorylation of IRS-1 through the insulin-like growth factor receptor is independent of JAK1, JAK2, or Tyk2. In contrast, phosphorylation of IRS-1 mediated by the Type I IFNs, IL-4, and OSM is JAK-dependent. For the alphabeta-IFNs, activation of IRS-1 is dependent on JAK1 and Tyk2, consistent with the interdependence of these kinases in the IFN-alphabeta response. Neither IRS-1 nor IRS-2 was detectably activated by IFN-gamma. Consistent with this, activation of neither IRS proteins appears to be an absolute requirement for an antiproliferative or an antiviral response to the IFNs. For IL-4 and OSM phosphorylation of IRS-1 in the human fibrosarcoma cells is largely dependent on JAK1 but can also be mediated through Tyk2 or JAK2. Activation of phosphatidylinositol 3'-kinase in response to IL-4 and OSM, at least, was also JAK-dependent. The JAKs are, therefore, required not only for STAT activation but also for the activation, through a variety of different types of cytokine receptor, of an additional signaling pathway(s) through IRS-1 and phosphatidylinositol 3'-kinase.


Asunto(s)
Interferones/farmacología , Interleucina-4/farmacología , Péptidos/farmacología , Fosfoproteínas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , División Celular , Línea Celular , Humanos , Proteínas Sustrato del Receptor de Insulina , Janus Quinasa 1 , Oncostatina M , Fosfatidilinositol 3-Quinasas , Fosforilación , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Receptor IGF Tipo 1/metabolismo
15.
Proc Natl Acad Sci U S A ; 94(16): 8563-8, 1997 Aug 05.
Artículo en Inglés | MEDLINE | ID: mdl-9238016

RESUMEN

Exposure of cells to protein tyrosine phosphatase (PTP) inhibitors causes an increase in the phosphotyrosine content of many cellular proteins. However, the level at which the primary signaling event is affected is still unclear. We show that Jaks are activated by tyrosine phosphorylation in cells that are briefly exposed to the PTP inhibitor pervanadate (PV), resulting in tyrosine phosphorylation and functional activation of Stat6 (in addition to other Stats). Mutant cell lines that lack Jak1 activity fail to support PV-mediated [or interleukin 4 (IL-4)-dependent] activation of Stat6 but can be rescued by complementation with functional Jak1. The docking sites for both Jak1 and Stat6 reside in the cytoplasmic domain of the IL-4 receptor alpha-chain (IL-4Ralpha). The glioblastoma-derived cell lines T98G, GRE, and M007, which do not express the IL-4Ralpha chain, fail to support Stat6 activation in response to either IL-4 or PV. Complementation of T98G cells with the IL-4Ralpha restores both PV-mediated and IL-4-dependent Stat6 activation. Murine L929 cells, which do not express the gamma common chain of the IL-4 receptor, support PV-mediated but not IL-4-dependent Stat6 activation. Thus, Stat6 activation by PV is an IL-4Ralpha-mediated, Jak1-dependent event that is independent of receptor dimerization. We propose that receptor-associated constitutive PTP activity functions to down-regulate persistent, receptor-linked kinase activity. Inhibition or deletion of PTP activity results in constitutive activation of cytokine signaling pathways.


Asunto(s)
Antígenos CD/metabolismo , Proteínas Tirosina Fosfatasas/metabolismo , Proteínas Tirosina Quinasas/metabolismo , Receptores de Interleucina/metabolismo , Transducción de Señal , Secuencia de Aminoácidos , Animales , Línea Celular , Proteínas de Unión al ADN/metabolismo , Regulación hacia Abajo , Humanos , Janus Quinasa 1 , Datos de Secuencia Molecular , Receptores de Interleucina-4 , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Factor de Transcripción STAT6 , Transactivadores/metabolismo
16.
Blood ; 90(2): 597-604, 1997 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-9226159

RESUMEN

The proliferation and differentiation of neutrophils is regulated by granulocyte-specific colony-stimulating factor (G-CSF). G-CSF uses a receptor of the cytokine receptor superfamily and, in common with all members of the family, induces the tyrosine phosphorylation and activation of members of the Janus protein tyrosine kinase (Jak) family. In both myeloid cells and a human fibrosarcoma cell line expressing the G-CSF receptor, G-CSF induces the tyrosine phosphorylation and activation of Jak1, Jak2, and Tyk2. In addition, G-CSF induces the tyrosine phosphorylation of the receptor and members of the signal transducers and activators of transcription (Stat) family, including Stat3, as well as Stat1 and Stat5, depending on the cells involved. Using mutant cell lines lacking various Jaks, we show here that Jak1 is critical for G-CSF-mediated Stat activation, whereas Jak2 or Tyk2 are either not required or play redundant or ancillary roles. In the absence of Jak1, G-CSF induces activation of Jak2 and Tyk2, but fails to induce receptor tyrosine phosphorylation and induces dramatically reduced levels of Stat activation. A kinase-inactive Jak2, when overexpressed in cells lacking endogenous Jak2, can suppress Jak1 activation, receptor phosphorylation, and Stat activation, suggesting competition in the receptor complex either for Jak1 binding or substrates. Because the requirement for Jak1 is very similar to that previously shown for interleukin-6 signaling, the data support the concept that the G-CSF receptor and gp130 are both structurally and functionally similar.


Asunto(s)
Factor Estimulante de Colonias de Granulocitos/farmacología , Proteínas de la Leche , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas , Receptores de Factor Estimulante de Colonias de Granulocito/fisiología , Animales , Línea Celular , Proteínas de Unión al ADN/metabolismo , Activación Enzimática , Fibrosarcoma , Humanos , Interferón gamma/farmacología , Interleucina-3/farmacología , Janus Quinasa 1 , Janus Quinasa 2 , Ratones , Fosforilación , Proteínas/metabolismo , Receptores de Factor Estimulante de Colonias de Granulocito/biosíntesis , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/farmacología , Factor de Transcripción STAT1 , Factor de Transcripción STAT3 , Factor de Transcripción STAT5 , TYK2 Quinasa , Transactivadores/metabolismo , Transfección , Células Tumorales Cultivadas
17.
Mol Cell Biol ; 17(5): 2497-501, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9111318

RESUMEN

The Janus protein tyrosine kinases (Jaks) play critical roles in transducing growth and differentiation signals emanating from ligand-activated cytokine receptor complexes. The activation of the Jaks is hypothesized to occur as a consequence of auto- or transphosphorylation on tyrosine residues associated with ligand-induced aggregation of the receptor chains and the associated Jaks. In many kinases, regulation of catalytic activity by phosphorylation occurs on residues within the activation loop of the kinase domain. Within the Jak2 kinase domain, there is a region that has considerable sequence homology to the regulatory region of the insulin receptor and contains two tyrosines, Y1007 and Y1008, that are potential regulatory sites. In the studies presented here, we demonstrate that among a variety of sites, Y1007 and Y1008 are sites of trans- or autophosphorylation in vivo and in in vitro kinase reactions. Mutation of Y1007, or both Y1007 and Y1008, to phenylalanine essentially eliminated kinase activity, whereas mutation of Y1008 to phenylalanine had no detectable effect on kinase activity. The mutants were also examined for the ability to reconstitute erythropoietin signaling in gamma2 cells, which lack Jak2. Consistent with the kinase activity, mutation of Y1007 to phenylalanine eliminated the ability to restore signaling. Moreover, phosphorylation of a kinase-inactive mutant (K882E) was not detected, indicating that Jak2 activation during receptor aggregation is dependent on Jak2 and not another receptor-associated kinase. The results demonstrate the critical role of phosphorylation of Y1007 in Jak2 regulation and function.


Asunto(s)
Proteínas de la Leche , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas , Transducción de Señal , Secuencia de Aminoácidos , Animales , Western Blotting , Proteínas de Unión al ADN/metabolismo , Activación Enzimática , Eritropoyetina/metabolismo , Janus Quinasa 2 , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Fosforilación , Factor de Transcripción STAT5 , Spodoptera , Relación Estructura-Actividad , Transactivadores/metabolismo
18.
Mol Cell Biol ; 17(4): 2048-56, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9121453

RESUMEN

Two members of the STAT signal transducer and activator of transcription family, STAT1 and STAT2, are rapidly phosphorylated on tyrosine in response to alpha interferon (IFN-alpha). Previous work showed that in the mutant human cell line U6A, which lacks STAT2 and is completely defective in IFN-alpha signaling, the phosphorylation of STAT1 is very weak, revealing that activation of STAT1 depends on STAT2. We now find that STAT2 binds to the cytoplasmic domain of the IFNAR2c (also known as IFNAR2-2) subunit of the IFN-alpha receptor in extracts of untreated cells. STAT1 also binds but only when STAT2 is present. The activities of chimeric STAT2-STAT1 proteins were assayed in U6A cells to define regions required for IFN-alpha signaling. Previous work showed that a point mutation in the Src homology 2 (SH2) domain prevents STAT2 from binding to phosphotyrosine 466 of the IFNAR1 subunit of the activated receptor. However, we now find that the entire SH2 domain of STAT2 can be replaced by that of STAT1 without loss of function, revealing that other regions of STAT2 are required for its specific interaction with the receptor. A chimeric protein, in which the N-terminal third of STAT2 has replaced the corresponding region of STAT1, did preassociate with the IFNAR2c subunit of the receptor, became phosphorylated when IFN-alpha was added, and supported the phosphorylation of endogenous STAT1. These results are consistent with a model in which STAT2 and STAT1 are prebound to the IFNAR2c subunit of the resting receptor. Upon activation, the IFNAR1 subunit is phosphorylated on Tyr-466, allowing the SH2 domain of STAT2 to bind to it; this is followed by the sequential phosphorylation of STAT2 and STAT1.


Asunto(s)
Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/metabolismo , Receptores de Interferón/metabolismo , Transactivadores/química , Transactivadores/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Línea Celular , Proteínas de Unión al ADN/genética , Dimerización , Humanos , Modelos Biológicos , Estructura Molecular , Mutación , Fragmentos de Péptidos/química , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/metabolismo , Fosforilación , Unión Proteica , Receptor de Interferón alfa y beta , Receptores de Interferón/química , Receptores de Interferón/genética , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Factor de Transcripción STAT1 , Factor de Transcripción STAT2 , Transducción de Señal , Transactivadores/genética , Transfección , Dominios Homologos src
19.
Mol Cell Biol ; 17(2): 695-706, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9001223

RESUMEN

Cell lines that are mutated in interferon (IFN) responses have been critical in establishing an essential role for the JAK family of nonreceptor tyrosine kinases in interferon signalling. Mutant gamma1A cells have previously been shown to be complemented by overexpression of JAK2. Here, it is shown that these cells carry a defect in, and can also be complemented by, the beta-subunit of the IFN-gamma receptor, consistent with the hypothesis that the mutation in these cells affects JAK2-receptor association. In contrast, mutant gamma2A cells lack detectable JAK2 mRNA and protein. By using gamma2A cells, the role of various domains and conserved tyrosine residues of JAK2 in IFN-gamma signalling was examined. Individual mutation of six conserved tyrosine residues, mutation of a potential phosphatase binding site, or mutation of the arginine residue in the proposed SH2-like domain had no apparent effect on signalling in response to IFN-gamma. Results with deletion mutants, however, indicated that association of JAK2 with the IFN-gammaR2 subunit requires the amino-terminal region but not the pseudokinase domain. Consistent with this, in chimeras with JAK1, the JAK2 amino-terminal region was required for receptor association and STAT1 activation. Conversely, a JAK1-JAK2 chimera with the amino-terminal domains of JAK1 linked to the pseudokinase and kinase domains of JAK2 is capable of reconstituting JAK-STAT signalling in response to IFN-alpha and -gamma in mutant U4C cells lacking JAK1. The specificity of the JAKs may therefore lie mainly in their structural interaction with different receptor and signalling proteins rather than in the substrate specificity of their kinase domains.


Asunto(s)
Interferón-alfa/farmacología , Interferón gamma/farmacología , Proteínas Tirosina Quinasas/genética , Proteínas Proto-Oncogénicas , Transducción de Señal/fisiología , Secuencia de Aminoácidos , Antígenos CD/genética , Antígenos CD/metabolismo , Secuencia de Bases , Línea Celular , ADN/metabolismo , Proteínas de Unión al ADN/metabolismo , Mutación del Sistema de Lectura , Humanos , Interleucina-6/farmacología , Janus Quinasa 1 , Janus Quinasa 2 , Datos de Secuencia Molecular , Mutación , Fosforilación/efectos de los fármacos , Proteínas Tirosina Quinasas/metabolismo , ARN Mensajero/genética , Receptores de Interferón/genética , Receptores de Interferón/metabolismo , Proteínas Recombinantes de Fusión , Proteínas Recombinantes , Factor de Transcripción STAT1 , Transactivadores/metabolismo , Receptor de Interferón gamma
20.
Mol Cell Biol ; 16(12): 6957-64, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-8943351

RESUMEN

The first STAT-containing transcription factor to be studied, the alpha-interferon-induced ISGF3, is composed of a Stat1:2 heterodimer and a weak DNA-binding protein, p48, that is a member of a growing family of proteins similar to the so-called interferon regulatory factor (IRF-1). The p48 and Stat1:2 heterodimer do not associate stably in the absence of DNA, but we show that amino acids approximately 150 to 250 of Stat1 and a COOH-terminal portion of p48 exhibit physical interaction, implying contact that stabilizes ISGF3. Moreover, amino acid exchanges within the Stat1 contact region diminish or abolish the functional activity of Stat1. This protein interaction domain may be important in other STAT proteins to recruit partners to multiprotein transcription factors.


Asunto(s)
Proteínas de Unión al ADN/genética , Transactivadores/genética , Factores de Transcripción/genética , Transcripción Genética , Factor 3 de Genes Estimulados por el Interferón , Subunidad gamma del Factor 3 de Genes Estimulados por el Interferón , Unión Proteica/genética , Factor de Transcripción STAT1 , Factor de Transcripción STAT2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA